The drug is still going through trials, but the medical company Lilly, behind it, is hopeful it can be rolled out soon. In ...

People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...

But this one, for Lilly’s first diabetes and weight-loss pill based on the GLP-1 hormone, was particularly fraught. Days ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

President Donald Trump has ordered the Department of Health and Human Services to standardize Medicare payments in an effort ...

People taking GLP-1s consumed less processed food, although they still craved it. As a growing number of people using ...

During a recent finance committee meeting, Deputy Comptroller Delano Dowell confirmed to the Common Council that so far in fiscal year 2024-2025, Buffalo has incumbered $2.1 million of unexpected ...

Medical conditions can limit which weight loss pills work safely for you. For example, you should avoid phentermine if you ...